Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020953501
Abstract: Background Although intravenous (IV) bisphosphonates are first-line medications for the management of hypercalcemia, studies examining their use in patients with preexisting renal dysfunction are limited. Objective The objective of this study is to describe the… read more here.
Keywords: renal dysfunction; hypercalcemia; preexisting renal; patients preexisting ... See more keywords
Effect of renal impairment (RI) on intravenous bisphosphonates (IVBP) and multiple myeloma (MM) treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20007
Abstract: e20007Background: RI is prevalent in MM patients and associated with poor survival and increased costs. IVBPs are recommended to prevent skeletal-related event (SREs), a common and devastating comp... read more here.
Keywords: bisphosphonates ivbp; ivbp multiple; effect renal; intravenous bisphosphonates ... See more keywords